Continuing Education

<51>Antimicrobial Effectiveness Testing, <71>Sterility Testing and Rapid Sterility Testing
Presenter: Brian Kelley
Objectives:

  1. Discuss antimicrobial preservative selection in compounded preparations and factors that may influence their effectiveness.
  2. Explain antimicrobial effectiveness testing per USP 51 for non-sterile and sterile preparations.
  3. Identify sterility testing per USP 797 for compounded sterile preparations, including practical examples.
  4. Define rapid sterility methods and explain FDA and USP requirements for rapid sterility method validation.
  5. Outline Factors to consider when implementing rapid sterility methods.

UAN: 0113-0000-24-001-L99-P; 0113-0000-24-001-L99-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Annual Immunization Update: 2024
Presenters: Richard Dang & Jeff Goad
Objectives:

  1. Review and interpret important changes to ACIP recommendations and the CDC’s immunization schedules for adults and children in the United States.
  2. Review newly licensed vaccine products and examine data on efficacy and safety.
  3. Examine information about the efficacy and safety of newly licensed vaccine products.
  4. Assess patient profiles and develop recommendations for immunizations based on age, medical indications, or other risk factors.

UAN: 0113-0000-24-016-L06-P; 0113-0000-24-016-L06-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/20/2024
Planned Expiration Date: 04/20/2027

 

Annual Wellness Visits: Are You Ready to Make Some Money?
Presenters: Albert Bach & Jelena Lewis
Objectives:

  1. Define Medicare’s Annual Wellness Visit and its requirements.
  2. Justify how pharmacists can play a role in conducting an Annual Wellness Visit.
  3. List the steps to conduct an Annual Wellness Visit.
  4. Propose how to implement Annual Wellness Visits into various pharmacy practice settings.

UAN: 0113-0000-24-008-L04-P; 0113-0000-24-008-L04-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Beyond Statins: A Review of Novel Lipid-Lowering Therapies
Presenters: Jennifer Ko & Laura Tsu
Objectives:

  1. Explain the pathophysiology of atherosclerotic cardiovascular disease and familial hypercholesterolemia.
  2. Summarize the outcomes of the ODYSSEY, FOURIER, ORION, and CLEAR Outcomes trials.
  3. Compare the clinical benefits and drawbacks of PCSK9 inhibitors, siRNA, and ACL inhibitor to statin therapy using guideline and consensus recommendations.
  4. Recommend the use of novel antilipidemic agents based on a patient case.

UAN: 0113-0000-24-015-L01-P; 0113-0000-24-015-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/20/2024
Planned Expiration Date: 04/20/2027

 

Burnout vs. Moral Injury: How They’re Different and Why It Matters
Presenters: Michael Negrete & Nancy Alvarez
Objectives:

  1. Summarize the literature detailing pharmacist/technician “shortages”.
  2. Compare and contrast the causes and symptoms of burnout vs. moral injury.
  3. Describe the expected consequences for NOT addressing “moral injury”.
  4. Compare and contrast the common interventions used to address burnout vs. moral injury.

UAN: 0113-0000-24-022-L04-P; 0113-0000-24-022-L04-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

California Pharmacy Law Update: 2024, Q1 (non-recorded)
Presenter: Tony J. Park
Objectives:

  1. Describe changes in state and federal pharmacy laws for 2024.
  2. Explain overarching trends in the regulatory climate for California pharmacists.
  3. Summarize current pharmacy standards of practice.
  4. Identify resources for staying current on regulatory issues.

UAN: 0113-0000-24-012-L03-P; 0113-0000-24-012-L03-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/20/2024
Planned Expiration Date: 04/20/2027

 

Cancer: How Is This Affected by the Intestinal Microbiota?
Presenter: Cynthia L. Lieu
Objectives:

  1. Discuss the relationship between the intestinal microbiota and cancer development.
  2. Discuss the relationship between the intestinal microbiota and response to anti-cancer therapies.
  3. Discuss how modifications of the intestinal microbiota may impact the response to anti-cancer therapies.

UAN: 0113-0000-24-011-L01-P; 0113-0000-24-011-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Contraception Update: What’s New
Presenters: Kathleen Besinque & Sarah McBane
Objectives:

  1. Discuss rates of unintended pregnancy and contraceptive use in the U.S.
  2. Compare the contraception options available in the US including the recently approved OTC hormonal product.
  3. Apply evidenced‐based guidelines to contraceptive provision using the CDC MEC.
  4. Provide resources and referral to persons seeking care for reproductive health-related conditions.

UAN: 0113-0000-24-018-L01-P; 0113-0000-24-018-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Disparities Among Patients Using the End-of-Life Option Act
Presenter: Jim Pinder
Objectives:

  1. List the requirements of the End-of-Life Option Act.
  2. Describe the demographic trends of the End-of-Life Option Act patient population since its implementation in 2016.
  3. Articulate possible reasons for these disparities.

UAN: 0113-0000-24-019-L03-P; 0113-0000-24-019-L03-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/21/2024
Planned Expiration Date: 04/21/2027

 

Forever Young: Embracing Age-Friendly Health Systems for Optimal Geriatric Care
Presenters: Christine Kim, Tatyana Gurvich & Patrick Tabon
Objectives:

  1. Identify the 4M’s of age-friendly health systems.
  2. Discuss resources utilized to develop an age-friendly health system.
  3. Outline various roles pharmacists can play in age-friendly health systems.
  4. Implement age-friendly health systems in practice.

UAN: 0113-0000-24-022-L04-P; 0113-0000-24-022-L04-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/21/2024
Planned Expiration Date: 04/21/2027

 

Glucose on the Go: Using Continuous Glucose Monitoring To Reach Glycemic Goals
Presenters: Rory E. Kim, Michelle Chu & Carla Blieden
Objectives:

  1. Describe the benefits of continuous glucose monitoring devices in the management of type 2 diabetes.
  2. Identify appropriate indications for continuous glucose monitoring in diabetes management.
  3. Demonstrate proficiency in counseling for a patient on the appropriate use of a continuous glucose monitoring device, including sensor application, setting up reader/application, and alerts.
  4. Describe the use of the ambulatory glucose profile (AGP) in setting glycemic treatment goals and adjusting diabetes therapy.
  5. Given a patient’s CGM data, utilize the AGP to analyze trends and formulate a treatment plan.

UAN: 0113-0000-24-020-L01-P; 0113-0000-24-020-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/21/2024
Planned Expiration Date: 04/21/2027

 

Impact of Explicit and Implicit Bias in Health Care
Presenters: Marisella Guerrero
Objectives:

  1. Describe various categories of bias and where they stem from.
  2. List examples of the bias that exists in health care.
  3. Describe how explicit and implicit bias contribute to health care disparities.
  4. Identify and reflect on one’s own biases.
  5. Describe methods used to mitigate bias.

UAN: 0113-0000-24-014-L99-P; 0113-0000-24-014-L99-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/20/2024
Planned Expiration Date: 04/20/2027

 

Multidisciplinary Fall Risk Assessment and Interventions in Community Dwelling Older Adults
Presenters: Gail Orum & Daniel Kudo
Objectives:

  1. Identify risk factors, incidence, and consequences of falls in older adults.
  2. Describe and employ the use of the CDC STEADI Rx Community Pharmacy Algorithm and the Community Pharmacy Fall Risk Checklist.
  3. Describe the outcomes of an existing falls intervention program.
  4. Identify methods and resources to educate patients and caregivers to mitigate fall risk.

UAN: 0113-0000-24-003-L05-P; 0113-0000-24-003-L05-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

New Updates on Asthma and COPD
Presenters: Brian Ma & Michelle Chu
Objectives:

  1. Describe the safety, effectiveness, and evidence behind the new ICS-SABA inhaler.
  2. Assess the appropriateness of a patient’s current asthma pharmacotherapy and track category.
  3. Compare differences in the ABCD COPD Assessment Tool and the ABE COPD Assessment Tool.
  4. Apply GOLD guidelines to recommend appropriate pharmacotherapy after COPD exacerbation.
  5. Assess COPD exacerbation characteristics with new GOLD guidelines recommendations.

UAN: 0113-0000-24-017-L01-P; 0113-0000-24-017-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/20/2024
Planned Expiration Date: 04/20/2027

 

Opioid/Trauma Discharge Counseling: The Process, the “Percs”, and Naloxone
Presenters: Amber Miller & Erin Bess
Objectives:

  1. Describe the current state of opioid discharge counseling and naloxone distribution at your institution.
  2. Identify potential opportunities for a novel opioid discharge counseling and naloxone distribution program at your institution.
  3. Develop a plan to create a successful opioid discharge counseling and naloxone in-hand program.
  4. Measure possible institutional benefits derived from an opioid discharge counseling and naloxone in-hand program.

UAN: 0113-0000-24-023-L01-P; 0113-0000-24-023-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/21/2024
Planned Expiration Date: 04/21/2027

 

Optimizing Cancer Patients Supportive Care Regimens in the Community Setting
Presenter: Fouad Boulbol
Objectives:

  1. Demonstrate an understanding on the class of medications used for prevention and treatment of chemotherapy induced nausea & vomiting, accompanied with clinical pearls of each class based on updated NCCN guidelines.
  2. Demonstrate an understanding of anti-infectives utilized in patient’s treatments, their dosing, duration, and unique considerations based on updated NCCN guidelines.
  3. Describe the purpose of growth factor support, and its role in cancer care.

UAN: 0113-0000-24-007-L99-P; 0113-0000-24-007-L99-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Pharmacists Role in the Prevention of Mental Health Relapse: Long-Acting Injectable Antipsychotics
Presenter: Jennifer Courtney
Objectives:

  1. Describe the role of the pharmacist in LAI antipsychotic administration in the ambulatory and community pharmacy setting.
  2. Identify and compare the FDA approved long-acting injectable antipsychotics (LAIAs) including their indications, mechanism of action, dosing and frequency, route of administration, preparation, missed doses, requirements for oral supplementation, and storage.
  3. Outline policies, procedures, workflow, reimbursement, inventory, and provider communication and feedback processes for administering long-acting injectables (LAIs).

UAN: 0113-0000-24-002-L01-P; 0113-0000-24-002-L01-P
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Prescribing Safe Journeys: Updated Travel Recommendations
From the CDC Yellow Book 2024″
Presenters: Edith Mirzaian, Nicki Mashayekan, & Ishani Wewala Panditha
Objectives:

  1. Identify current resources and guidelines for providing travel vaccines, precautions, and recommendations.
  2. Discuss the 2024 CDC Yellow Book updates and changes to travel health recommendations.
  3. Describe the new precautions for international travelers during the COVID-19 pandemic.
  4. Apply new guideline recommendations to case-based scenarios.

UAN: 0113-0000-24-006-L06-P; 0113-0000-24-006-L06-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Psychotropic Medications for the Non-Specialists
Presenter: Jody Jacobson Wedret
Objectives:

  1. Match basic psychiatric symptoms with appropriate medication classifications.
  2. State realistic expectations for outcomes from agents used in psychiatry.
  3. Identify drug classes, agents and usual side effects.
  4. Develop basic skill sets to address psychiatric concerns,
  5. Recognize community resources to help patients with psychiatric disorders.

UAN: 0113-0000-24-004-L06-P; 0113-0000-24-004-L06-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

Quality Improvement and Pharmacy: Fundamentals
Presenter: George Do
Objectives:

  1. Define Quality Improvement.
  2. Understand role and influence of other members of interdisciplinary team.
  3. Determine what Quality Improvement tools are best in various scenarios.
  4. Reproduce results in clinical studies to specific work settings.
  5. Relate obstacles to quality improvement.

UAN: 0113-0000-24-013-L04-P; 0113-0000-24-013-L04-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/20/2024
Planned Expiration Date: 04/20/2027

 

SGLT“2” Good to be True? Renal Outcomes of SGLT2 Inhibitors
Presenters:
Objectives:

  1. Outline current guidelines and the role of SGLT2 inhibitors in kidney disease.
  2. Review the literature regarding SGLT2 inhibitors and their place in patients with kidney disease.
  3. Define optimal patients to initiate on SGLT2 inhibitors.

UAN: 0113-0000-24-009-L01-P; 0113-0000-24-009-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

To the Point: Advanced Injection Techniques for Vaccinations and Medication Administration
Presenters: Richard Dang, Allison Chacon, and Terrance Ito
Objectives:

  1. List and describe the steps for intramuscular, subcutaneous, and intradermal injection.
  2. Identify alternate site locations for injections, such as the vastus lateralis, gluteal, or forearm.
  3. Identify best practices to reduce errors related to the handling and administration of vaccines.

UAN: 0113-0000-23-014-L01-P; 0113-0000-23-014-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

What Are My Options to Lose Weight – Medications or Surgery?
Presenter: Hyma Gogineni
Objectives:

  1. Describe the health consequences of obesity and benefits of weight loss.
  2. Discuss pharmacotherapy options to treat obesity in the US.
  3. Discuss appropriate dosing, pros and cons of each of anti-obesity agent given a patient case.
  4. Discuss pharmacotherapy options vs weight loss surgery.
  5. Describe the role of therapeutic lifestyle for overall health.

UAN: 0113-0000-24-010-L01-P; 0113-0000-24-010-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/19/2024
Planned Expiration Date: 04/19/2027

 

When Cannabis Is Medicine: Its Physiological Impacts and Clinical Applications
Presenters: Jill Simonian, Kari Franson, Codi Peterson, Leah Johnson, & Paul Lofholm
Objectives:

  • Define and describe the three primary components that constitute the endocannabinoid system
  • Correlate the physiological action of cannabis with potential therapeutic uses
  • Identify common and rare adverse effects of cannabis and evaluate drug interaction potential
  • Devise a cannabis dosing, titration, and monitoring plan for a patient

UAN: 0113-0000-24-028-L01-P; 0113-0000-24-028-L01-T
Activity Length: 1 hour (0.1 CEU)
Initial Release Date: 04/21/2024
Planned Expiration Date: 04/21/2027